BR112013017501A2 - composições e métodos de polissacarídios de aloé - Google Patents

composições e métodos de polissacarídios de aloé

Info

Publication number
BR112013017501A2
BR112013017501A2 BR112013017501A BR112013017501A BR112013017501A2 BR 112013017501 A2 BR112013017501 A2 BR 112013017501A2 BR 112013017501 A BR112013017501 A BR 112013017501A BR 112013017501 A BR112013017501 A BR 112013017501A BR 112013017501 A2 BR112013017501 A2 BR 112013017501A2
Authority
BR
Brazil
Prior art keywords
methods
polysaccharide compositions
aloe polysaccharide
extract
present
Prior art date
Application number
BR112013017501A
Other languages
English (en)
Other versions
BR112013017501B1 (pt
Inventor
Ivan E Danhof
Original Assignee
North Texas Medical Ass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Texas Medical Ass filed Critical North Texas Medical Ass
Publication of BR112013017501A2 publication Critical patent/BR112013017501A2/pt
Publication of BR112013017501B1 publication Critical patent/BR112013017501B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

composições e métodos de polissacarídios de aloé a presente invenção descreve um método para preparação de um extrato de polimanana de pó de aloé por congelamento - dessecação. o extrato de polimanana da presente invenção é ainda usado para preparar uma formulação injetável estéril destinada ao tratamento de um ou mais cânceres, leucemias e linfomas, câncer de próstata, câncer de mama e câncer de cólon, doenças imunes, particularmente neoplasias relacionadas com o sistema imunológico, síndrome de deficiência imune adquirida e hepatite c.
BR112013017501-0A 2011-01-06 2011-01-06 Método para preparação de um pó fino de um extrato de polimanana, uso do pó fino doextrato de polimanana, formulação injetável de um extrato de polimanana e uso de formulação injetável BR112013017501B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/020402 WO2012094010A1 (en) 2011-01-06 2011-01-06 Compositions and methods of aloe polysaccharides

Publications (2)

Publication Number Publication Date
BR112013017501A2 true BR112013017501A2 (pt) 2016-09-27
BR112013017501B1 BR112013017501B1 (pt) 2020-10-27

Family

ID=46457644

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013017501-0A BR112013017501B1 (pt) 2011-01-06 2011-01-06 Método para preparação de um pó fino de um extrato de polimanana, uso do pó fino doextrato de polimanana, formulação injetável de um extrato de polimanana e uso de formulação injetável

Country Status (17)

Country Link
EP (1) EP2661274B1 (pt)
JP (1) JP5886877B2 (pt)
KR (5) KR20180120799A (pt)
CN (2) CN108503723A (pt)
AU (4) AU2011353765B2 (pt)
BR (1) BR112013017501B1 (pt)
CA (1) CA2822300C (pt)
DK (1) DK2661274T3 (pt)
ES (1) ES2742220T3 (pt)
IL (2) IL227093B (pt)
MX (2) MX358484B (pt)
MY (1) MY194961A (pt)
NZ (1) NZ612024A (pt)
RU (1) RU2587784C2 (pt)
SG (1) SG191336A1 (pt)
WO (1) WO2012094010A1 (pt)
ZA (1) ZA201304789B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604187B2 (en) 2010-01-14 2013-12-10 North Texas Medical Associates Compositions and methods of aloe polysaccharides
CN103876014B (zh) * 2014-03-31 2015-07-08 福建农林大学 一种复方桑黄口服液及其制备方法
CN106456524B (zh) 2014-04-17 2019-12-10 荷兰联合利华有限公司 个人护理组合物
JP2017511349A (ja) 2014-04-17 2017-04-20 ユニリーバー・ナームローゼ・ベンノートシヤープ パーソナルケア組成物用アロエベラ抽出物
US9993416B1 (en) * 2017-04-24 2018-06-12 Shen Wei (Usa) Inc. Hydrating elastomeric flexible article with natural bioactives and manufacturing method
CN110270132A (zh) * 2018-07-20 2019-09-24 何晴雪 一种甜叶菊糖液提取装置的使用方法
CN109320626B (zh) * 2018-10-08 2020-06-23 伍曾利 一种芦荟多糖及其制备方法与应用
CN111467365A (zh) * 2019-01-24 2020-07-31 开封九福来生物技术有限公司 含有石斛多糖的口腔速溶膜剂及其制备方法
WO2022046975A1 (en) * 2020-08-28 2022-03-03 Herbalife International Of America, Inc. Compositions comprising neutral and acidic polysaccharides of aloe vera and their uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2106616A (en) * 1935-11-06 1938-01-25 Locke Insulator Corp Switch and bus insulator stack
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
US5118673A (en) * 1982-05-07 1992-06-02 Carrington Laboratories, Inc. Uses of aloe products
US20030096378A1 (en) * 1997-10-10 2003-05-22 Univera Pharmaceuticals, Inc. Process for the preparation of immunomodulatory polysaccharides from aloe
KR100678238B1 (ko) * 1997-10-10 2007-02-01 유니젠 파아마슈티컬스,인크. 알로에로부터 면역조절성 다당류를 제조하는 방법
EP1144456A3 (en) * 1999-01-12 2002-09-11 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
WO2002003999A1 (en) * 2000-07-10 2002-01-17 The University Of Missisippi High molecular weight polysaccharide fraction from aloe vera with immunostimulatory activity
CN1362105A (zh) * 2001-01-04 2002-08-07 杨孟君 纳米当归龙荟制剂药物及其制备方法
KR20020075622A (ko) * 2001-03-26 2002-10-05 김세웅 고기 구이장치
JP4871735B2 (ja) * 2004-05-21 2012-02-08 俊一 八木 アロエパウダーの製造方法
US20060084629A1 (en) * 2004-10-15 2006-04-20 Alvin Needleman Immune system activating formula composed of selected long chain polysaccharides from natural sources
CN101070354B (zh) * 2007-05-18 2010-04-07 中南大学 一种利用芦荟同时生产芦荟多糖粉、芦荟活性水的方法
CN101306012A (zh) * 2008-06-19 2008-11-19 中国人民解放军第四军医大学 富含甘露糖的改性多糖在制备阻止结肠炎癌变的药物中的应用

Also Published As

Publication number Publication date
KR20180122031A (ko) 2018-11-09
MX2013007561A (es) 2013-12-02
KR20170038085A (ko) 2017-04-05
AU2011353765B2 (en) 2017-04-06
CA2822300C (en) 2021-07-20
BR112013017501B1 (pt) 2020-10-27
CN103338781A (zh) 2013-10-02
KR20140092235A (ko) 2014-07-23
EP2661274A4 (en) 2014-08-20
ES2742220T3 (es) 2020-02-13
AU2019200361B2 (en) 2020-07-30
AU2011353765A1 (en) 2013-07-04
AU2020250236A1 (en) 2020-11-05
IL227093B (en) 2018-04-30
AU2017202499A1 (en) 2017-05-04
ZA201304789B (en) 2014-12-23
MX358484B (es) 2018-08-22
DK2661274T3 (da) 2019-08-26
KR20180120799A (ko) 2018-11-06
KR101725584B1 (ko) 2017-04-10
WO2012094010A1 (en) 2012-07-12
RU2013127633A (ru) 2015-02-20
CN108503723A (zh) 2018-09-07
KR20170015554A (ko) 2017-02-08
RU2587784C2 (ru) 2016-06-20
AU2019200361A1 (en) 2019-02-07
EP2661274A1 (en) 2013-11-13
NZ612024A (en) 2015-02-27
SG191336A1 (en) 2013-07-31
MY194961A (en) 2022-12-28
AU2020250236B2 (en) 2022-09-29
IL253716A0 (en) 2017-09-28
AU2017202499B2 (en) 2018-12-06
EP2661274B1 (en) 2019-05-22
JP2014501777A (ja) 2014-01-23
JP5886877B2 (ja) 2016-03-16
CA2822300A1 (en) 2012-07-12
IL253716B (en) 2020-03-31

Similar Documents

Publication Publication Date Title
BR112013017501A2 (pt) composições e métodos de polissacarídios de aloé
CY1123649T1 (el) Παραγωγα ιμιδαζολινης, μεθοδοι παρασκευης αυτων και εφαρμογες αυτων στην ιατρικη
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
NZ752526A (en) Pyrrolobenzodiazepine conjugates
IN2014MN02069A (pt)
PH12016501898B1 (en) Quinoxaline derivatives useful as fgfr kinase modulators
CL2015003395A1 (es) Derivados pirazolopirrolidina y su uso en el tratamiento de la enfermedad
PH12015501552A1 (en) Androgen receptor modulator and uses thereof
MX366503B (es) Derivados de amatoxina.
BR112016012713A2 (pt) Método para tratamento de câncer em um paciente necessitado, e, método de selecionar um paciente para um método de tratamento
MX340090B (es) Analogos de spliceostatina.
EA201691059A1 (ru) Соединения-пептидомиметики и содержащие их конъюгаты антитело-лекарственное средство
MX356205B (es) Benzopirazinas anticancerigenas via la inhibicion de cinasas del receptor del factor de crecimiento de fibroblasto (fgfr).
BR112016011734A2 (pt) Indóis substituídos e funcionalizados como agentes anti-câncer
CL2016000063A1 (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
MX2016003660A (es) Conjugados de partícula similar a virus para el diagnóstico y tratamiento de tumores.
MX2017004661A (es) 17alfa-benzoato de cortexolona para uso en el tratamiento de tumores.
BR112018011817A2 (pt) derivado de benzopiperidina, método de preparação do mesmo, e uso médico do mesmo
BR112016024421A2 (pt) composição farmacêutica, cápsula e uso da composição farmacêutica
MD20160018A2 (ro) Noi compuşi de izoindolină sau izochinolină, procedeu de obţinere a lor şi compoziţii farmaceutice care îi conţin
IN2013MU03118A (pt)
BR112015030292A2 (pt) composições farmacêuticas
MY170968A (en) Compositions and methods of aloe polysaccharides
BR112017014162A2 (pt) imidazo[1,2-a] quinoxalinas e derivados do mesmo para o tratamento dos cânceres
BR112013017909A8 (pt) composição farmacêutica e simalikalactona e.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: BESPOKE BIOSCIENCE, LLC (US)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/01/2011, OBSERVADAS AS CONDICOES LEGAIS.